Promising Thrombin Biomarkers For Identifying High-Risk VTE Patients – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Geke C. Poolen et al, adding:
”Thrombin Generation and Thrombin Dynamics Are Associated with Recurrent Venous Thromboembolism After Anticoagulation Withdrawal
In 589 VTE patients, reduced endogenous thrombin potential, thrombomodulin sensitivity, and thrombin inactivation by antithrombin were significantly associated with VTE recurrence after stopping anticoagulation, highlighting these parameters as promising biomarkers for identifying high-risk patients.”
Title: Thrombin generation and thrombin dynamics are associated with recurrent venous thromboembolism after anticoagulation withdrawal
Authors: Geke C. Poolen, Romy M.W. de Laat-Kremers, Mark Roest, Geert-Jan Geersing, Rolf T. Urbanus, Bas de Laat, Roger E.G. Schutgens
Read the Full Article on JTH
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 22, 2026, 09:18Shamee Shastry: How Transfusion Medicine Research Is Evolving in India
-
Sep 22, 2026, 09:11Tarique Shahzad Chachar: Why Warfarin Remains the Gold Standard for Mechanical Heart Valves
-
Sep 22, 2026, 09:04Bianca Rocca: Thromboinflammatory Injury in Ischemic Limb Necrosis During Severe Shock
-
Sep 22, 2026, 09:01Ash Paul: Comparing Left Atrial Appendage Occlusion and Oral Anticoagulation
-
Sep 22, 2026, 08:50Emily Horner: Lipoprotein(a) Links Oxidized Phospholipids to Platelet Hyperactivity
-
Sep 22, 2026, 08:42Sally Mandour: Bone Marrow Needle Gauge Explained
-
Sep 22, 2026, 08:39Alessandro Sionis: Navigating Anticoagulation in Mechanical Circulatory Support
-
Sep 22, 2026, 08:28Raghavendra Rao: The Latest Research on Varicose Veins
-
Sep 22, 2026, 08:23Aravind Palraj: Three Essential Tests in Antiphospholipid Syndrome